Pinsent Masons advises Northern Gritstone on £215m fund raising

20 May 2022 | 08:32 am | 1 min. read

Multinational law firm Pinsent Masons has advised the new investment business Northern Gritstone, founded by the Universities of Leeds, Manchester and Sheffield, on its £215m fund raising.

The transaction, which has led to funding commitments from a diverse investor base, will underpin Northern Gritstone’s investment programme focused on university spin-outs in the North of England. The project will see university spin-outs of science and innovation-based specialists leading to the launch of a number of start-ups across the region.
Investors include Greater Manchester Pension Fund, West Yorkshire Pension Fund, M&G, Columbia Threadneedle, Lansdowne Partners, Patron Capital, Greater Manchester Combined Authority and Bruntwood as well as Andrew Law, the CEO of Caxton Associates.
A team at Pinsent Masons was led by universities partner Gayle Ditchburn and corporate partners Julian Stanier and Sunjay Malhotra.
Commenting on the deal Gayle Ditchburn said: “This is a transformational fund raising which will deliver substantial investment to university spinouts across the North aimed at delivering investment gains for the founding universities and economic growth in the region. Combining our education sector and corporate finance expertise has enabled us to support the founding universities and Northern Gritstone on this strategic project which signals a new era for the financing of higher education spin-outs in the UK.”
Northern Gritstone’s total target fund raising is £500m and is expected to begin deploying capital and making its first investments to start-ups in the coming weeks.
Northern Gritstone Chairman, Lord Jim O’Neill said: “The strong endorsement of Northern Gritstone we’ve seen from investors is testament to the huge scale of the opportunity in northern England’s world class science and innovation hubs and the spin outs they are producing. By investing in Northern Gritstone, asset managers are directly buying into the brightest prospects for Britain’s future economy.
“Today marks a significant milestone as Northern Gritstone continues to build its investor base allowing the company to deliver its philosophy of Profit with Purpose which underpins all we seek to do.”

Latest press releases

Show me all press releases

Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London

Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises La Bottega on Australian acquisition

Multinational law firm Pinsent Masons has advised Italian producer of hotel essentials La Bottega on its acquisition of a majority stake in Australian company Vanity Group.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises Bestinver Infra, FCR on acquisition of remaining shares in Irish toll road concession & operation companies

Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.